Equillium (EQ) Other Operating Expenses (2018 - 2025)

Equillium (EQ) reported Other Operating Expenses of $901000.0 for Q3 2025, down 96.09% quarter-over-quarter from $23.0 million in Q1 2022.

Equillium (EQ) Other Operating Expenses (2018 - 2025) Analysis & Trends

Equillium (EQ) has 3 years of Other Operating Expenses data on file, last reported at $901000.0 in Q3 2025.

Other Operating Expenses for Q3 2025 came in at $901000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $901000.0 (changed N/A YoY), and the FY2022 annual result was $23.0 million, changed N/A from the prior year.
Other Operating Expenses declined to $901000.0 in Q3 2025 per EQ's latest filing, from $23.0 million in the prior quarter.
Over five years, Other Operating Expenses peaked at $23.0 million in Q1 2022 and troughed at $901000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Equillium	293.17 Mn	232.78 Mn	-

Download Data